Two-Symmetry Penning-Ioffe Trap for Antihydrogen Cooling and Spectroscopy

Autor: D. Grzonka, E. Tardiff, Nathan Jones, E. Nottet, Cole Meisenhelder, G. Khatri, D. Martinez Zambrano, X. Fan, Gerald Gabrielse, E. A. Hessels, W.S. Kolthammer, C. D. Hamley, E. Novitski, Tharon Morrison, C. H. Storry

Publikováno v: Nuclear instruments & methods in physics research / A 977, 164279-(2020). doi:10.1016/j.nima.2020.164279

High-accuracy spectroscopic comparisons of trapped antihydrogen atoms ($\overline{\text{H}}$) and hydrogen atoms ($\text{H}$) promise to stringently test the fundamental CPT symmetry invariance of the standard model of particle physics. ATRAP's neste

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3b959287592a12cdb61bf376cad5650

Reducing the costs of phase III cardiovascular clinical trials

Autor: Kevin A. Schulman, Robert M. Califf, Eric L. Eisenstein, M. King Jolly, Philip W. Lemons, Barbara E. Tardiff

Publikováno v: American Heart Journal. 149:482-488

The pharmaceutical industry spends approximately 26.4 billion dollars annually for research and development (4.1 billion dollars in cardiovascular products). We compared pharmaceutical companies' planned resource use and costs in Phase III cardiovasc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc1e0354a31a12253c207d586bd569e6
https://doi.org/10.1016/j.ahj.2004.04.049

A Dose-Determining Trial of Heparinase-I (Neutralase™) for Heparin Neutralization in Coronary Artery Surgery

Autor: Barbara E. Tardiff, Jay Horrow, Glenn P. Gravlee, Thomas Barragry, John Luber, Joel Schneider, Richard Broughton, Edward K. Heres

Publikováno v: Anesthesia & Analgesia. 93:1446-1452

Heparinase-I, a specific heparin-degrading enzyme, may represent an alternative to protamine. We explored the dose of heparinase-I for efficacy and safety in patients undergoing coronary artery surgery. At the conclusion of cardiopulmonary bypass, su

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::745607150e717a9638ada2fad5fe0e93
https://doi.org/10.1097/00000539-200112000-00019

Systematic adjudication of myocardial infarction end-points in an international clinical trial

Autor: Kenneth W, Mahaffey, Robert A, Harrington, Martijn, Akkerhuis, Neal S, Kleiman, Lisa G, Berdan, Brian S, Crenshaw, Barbara E, Tardiff, Christopher B, Granger, Ingrid, DeJong, Manju, Bhapkar, Petr, Widimsky, Ramón, Corbalon, Kerry L, Lee, Jaap W, Deckers, Maarten L, Simoons, Eric J, Topol, Robert M, Califf

Publikováno v: Current Controlled Trials in Cardiovascular Medicine, Vol 2, Iss 4, Pp 180-186 (2001)
Current Controlled Trials in Cardiovascular Medicine

Background Clinical events committees (CEC) are used routinely to adjudicate suspected end-points in cardiovascular trials, but little information has been published about the various processes used. We reviewed results of the CEC process used to ide

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::59a5b6015422b812fa836a1a3be435a2
http://cvm.controlled-trials.com/content/2/4/180

Practical Issues in and Applications of Clinical Data Mining

Autor: David Olaleye, Barbara E. Tardiff

Publikováno v: Drug Information Journal. 35:791-808

Pharmaceutical and biotechnology companies accumulate large volumes of data throughout the drug development life cycle-from discovery through marketing. Many organizations consolidate these data assets in central repositories to facilitate access and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4a2f933a49132631c6a8e1bb723c001d
https://doi.org/10.1177/009286150103500317